SCHEMBL13664192

SCHEMBL13664192

Cc1ccc(C(=O)c2nn(-c3ccc(-c4ccccc4)cc3)c(N)c2C#N)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.56
MAPT P10636 4/20 0.56
HPGD P15428 3/20 0.56
LMNA P02545 1/20 0.56
NPC1 O15118 1/20 0.47
TP53 P04637 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
KDM4E B2RXH2 4/20 0.46
RXFP1 Q9HBX9 1/20 0.46
GAA P10253 2/20 0.44
TSHR P16473 1/20 0.44
ADORA2A P29274 2/20 0.43
ADORA1 P30542 2/20 0.43
CYP2C9 P11712 3/20 0.43
CYP1A2 P05177 1/20 0.43
POLB P06746 1/20 0.42
CYP3A4 P08684 2/20 0.41
CYP2C19 P33261 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13664172 0.93 MAPT (0.64) ALDH1A1MAPTHPGDLMNANPC1
SCHEMBL13664173 0.92 MAPT (0.55) ALDH1A1MAPTHPGDLMNASMN1; SMN2
SCHEMBL13664246 0.89 MAPT (0.48) ALDH1A1MAPTHPGDLMNANPC1
SCHEMBL13664163 0.87 MAPT (0.51) ALDH1A1MAPTHPGDLMNASMN1; SMN2
SCHEMBL13664203 0.86 MAPT (0.50) ALDH1A1MAPTHPGDLMNANPC1
SCHEMBL13664161 0.86 MAPT (0.51) ALDH1A1MAPTHPGDLMNASMN1; SMN2
SCHEMBL13664170 0.86 MAPT (0.50) ALDH1A1MAPTHPGDLMNANPC1
SCHEMBL13664162 0.86 MEN1 (0.51) ALDH1A1MAPTHPGDLMNANPC1
SCHEMBL13664165 0.85 KMT2A (0.51) ALDH1A1MAPTHPGDLMNASMN1; SMN2
SCHEMBL13664178 0.85 KMT2A (0.51) ALDH1A1MAPTHPGDLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090253673-A1 Substituted Pyrazoles as Ghrelin Receptor Antagonists MERCK SHARP & DOHME CORP. 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253673-A1 Substituted Pyrazoles as Ghrelin Receptor Antagonists GIPR, GPR119, GLP1R ALDH1A1 3415/4885MAPT 4701/4885HPGD 1323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.